Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20848347 | 0.94 | CYP3A4 (0.39) | POLBCYP3A4DDB1CRBNALDH1A1 | |
| SCHEMBL21011264 | 0.90 | MEN1 (0.42) | POLBCYP3A4DDB1CRBNALDH1A1 | |
| SCHEMBL18256732 | 0.89 | NAAA (0.41) | POLBSMN1; SMN2ALDH1A1CA2CA9 | |
| SCHEMBL15198823 | 0.89 | NAAA (0.41) | POLBCYP3A4DDB1CRBNALDH1A1 | |
| SCHEMBL12938576 | 0.87 | POLB (0.38) | POLBCYP3A4DDB1CRBNHPGD | |
| SCHEMBL846827 | 0.87 | ALDH1A1 (0.47) | DDB1CRBNALDH1A1CA12CA2 | |
| SCHEMBL24885613 | 0.85 | NAAA (0.44) | POLBSMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL28897145 | 0.84 | POLB (0.36) | POLBCYP3A4DDB1CRBNHPGD | |
| SCHEMBL663919 | 0.75 | ATM (0.50) | POLBCYP3A4SMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL18257753 | 0.74 | CHRM5 (0.34) | SMN1; SMN2CA12CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11180608-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-11149114-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-10-19 | — | — | US | disclosed |
| US-10980234-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10779539-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC. (US) | 2020-09-22 | — | — | US | disclosed |
| EP-3259292-B1 | BLOCK COPOLYMERS WITH SURFACE-ACTIVE JUNCTION GROUPS, COMPOSITIONS AND PROCESSES THEREOF | AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) | 2020-04-08 | — | — | EP | disclosed |
| US-10457759-B2 | Co-delivery of cholesterol lowering drugs and nutraceuticals | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2019-10-29 | — | — | US | disclosed |
| US-10259907-B2 | Block copolymers with surface-active junction groups, compositions and processes thereof | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.À R.L. (LU) | 2019-04-16 | — | — | US | disclosed |
| US-20190023824-A1 | CO-DELIVERY OF CHOLESTEROL LOWERING DRUGS AND NUTRACEUTICALS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-01-24 | — | — | US | disclosed |
| WO-2011078804-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011078805-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-06-30 | — | — | WO | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11149114-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | DCLRE1A, ODC1, MRTO4 | POLB 688/4885CYP3A4 4096/4885DDB1 804/4885 |
| US-11180608-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | DCLRE1A, ODC1, MRTO4 | POLB 688/4885CYP3A4 4096/4885DDB1 804/4885 |
| US-10980234-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | POLB 1100/4885CYP3A4 4085/4885DDB1 1493/4885 |
| US-10457759-B2 | Co-delivery of cholesterol lowering drugs and nutraceuticals | STARD3, HMGCR, CETP | POLB 2139/4885CYP3A4 493/4885DDB1 1150/4885 |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | POLB 1100/4885CYP3A4 4085/4885DDB1 1493/4885 |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | MLEC, NOD2, PAM | POLB 249/4885CYP3A4 4614/4885DDB1 891/4885 |
| US-20190023824-A1 | CO-DELIVERY OF CHOLESTEROL LOWERING DRUGS AND NUTRACEUTICALS | STARD3, HMGCR, CETP | POLB 2139/4885CYP3A4 493/4885DDB1 1150/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | POLB 707/4885CYP3A4 2622/4885DDB1 3354/4885 |
| US-10779539-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | POLB 1100/4885CYP3A4 4085/4885DDB1 1493/4885 |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | SAMM50, ADRM1, UFM1 | POLB 451/4885CYP3A4 947/4885DDB1 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.